Higher expression of GHET1 was associated with poorer OS (HR = 2.30, 95% CI: 1.75‐3.02), and the subgroup meta‐analysis stratified by analysis type, cancer type, sample size and follow‐up time showed the similar results. Here, GHET1 is linked to cancer.